A recent study indicates that people who stop using popular slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who end conventional diet and exercise plans.
Research printed in a leading health publication demonstrates that while overweight people can lose about a fifth of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Individuals using such drugs should be informed of the risk of fast weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to pre-treatment weight within about one and a half years.
Weighing Therapies
The study, which reviewed dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with conventional dieting.
Scientists emphasize that individuals who shed pounds through diet and exercise generally see a slower weight regain—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Nutrition scientists propose the way of the drugs is key to understanding the accelerated regain.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making overeating far more likely."
A Chronic Issue?
Medical guidelines suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, given the high risk of weight regain, the treatment is often long-term.
This view is supported by pharmaceutical companies, who say that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Individuals who have discontinued the jabs describe a intense resurgence of hunger.
"It felt as if a trigger that goes on and you become ravenous," described one woman.
This difficulty is exacerbated if patients have not developed permanent lifestyle or habit changes during therapy.
Significant Use
Recent estimates suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is greater among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic cure and maintained weight loss hinges on integrated behavioural support.
